摘要:
The present invention provides novel crystalline polymorphs of enantiopure Erdosteine, referred to as Form I and Form II, and processes for the preparation thereof.
摘要:
The present invention relates to a process for the preparation of enantiomerically pure homocysteine-γ-thiolactone comprising optical resolution of racemic homocysteine-γ-thiolactone ( I )
with a chiral organic acid wherein one isomer is recovered as diastereomeric salt with the organic acid and the other isomer remaining in the mother liquor is submitted to racemisation with a catalytic amount of an aromatic aldehyde and submitted again to optical resolution with the same chiral organic acid.
摘要:
The use of N-(thiodiglycoyl)homocysteine, of the pharmaceutically acceptable salts thereof and of the metabolic precursors thereof for the preparation of medicaments for inhibiting bacterial adhesiveness. Novel metabolic precursors of N-(thiodiglycoyl)homocysteine are also disclosed.
摘要:
The use of N-(thiodiglycoyl)homocysteine, of the pharmaceutically acceptable salts thereof and of the metabolic precursors thereof for the preparation of medicaments for inhibiting bacterial adhesiveness. Novel metabolic precursors of N-(thiodiglycoyl)homocysteine are also disclosed.